Jump to content


Biomarker for Diffuse Scleroderma skin has been discovered!


Photo

Use of Mesenchymal Stem Cells (MSC) in Chronic Inflammatory Fistulizing and Fibrotic Diseases: a Comprehensive Review.


  • Please log in to reply
No replies to this topic

#1 Joelf

Joelf

    Star Ruby Member

  • ISN Root Admin
  • PipPipPipPipPipPipPipPipPipPipPipPipPip
  • 4,610 posts
  • Location:West Sussex

Posted 26 February 2013 - 11:47 PM

Use of Mesenchymal Stem Cells (MSC) in Chronic Inflammatory Fistulizing and Fibrotic Diseases: a Comprehensive Review.

 

The current data indicate that MSC represent a promising alternative strategy and encouraging results in the treatment of Crohn's disease, Systemic Lupus Erythematosus (SLE) and Systemic Sclerosis. PubMed, Clin Rev Allergy Immunol. 2013 Jan 8. (Also see: Lupus Treatments and Scleroderma Clinical Trials)

 

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.


Jo Frowde
ISN Assistant Webmaster

SD World Webmaster
ISN Sclero Forums Manager
ISN News Manager

ISN Hotline Support Specialist
ISN Chat Host
International Scleroderma Network (ISN)